Live from the NIH registry
Studies recruiting near Brownsville right now
Top 25 of 61 recruiting studies, sorted by proximity — each links to its official registry page
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
South Texas Research Institute (STRI) - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Regeneron Pharmaceuticals
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Texas Oncology - Central South — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0305 — Harlingen, Texas (19.9 mi)
· Sponsor: Bristol-Myers Squibb
Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions
Acute Ischemic Stroke
N/A
Interventional 170 participants sought
Valley Baptist Medical Center - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: RapidPulse, Inc
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Naiara Alvarez MD Integrative Rheumatology of South TX — Harlingen, Texas (19.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
Phase 3
Interventional 240 participants sought
Research Site — Harlingen, Texas (19.9 mi)
· Sponsor: AstraZeneca
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Lupus Nephritis
Phase 4
Interventional 150 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Aurinia Pharmaceuticals Inc.
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Obesity or Overweight
Phase 3
Interventional 2,000 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Hoffmann-La Roche
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Cano Medical Center — Harlingen, Texas (19.9 mi)
· Sponsor: Hoffmann-La Roche
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Brownsville, Texas (7.1 mi)
· Sponsor: AstraZeneca
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Valley Baptist Medical Center — Harlingen, Texas (19.9 mi)
· Sponsor: Medical University of South Carolina
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Kailera
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Texas Oncology - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: BriaCell Therapeutics Corporation
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Proactive RGV — Brownsville, Texas (7.1 mi)
· Sponsor: Uniquity One (UNI)
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Overweight, Obesity
Phase 3
Interventional 650 participants sought
Pinnacle Clinical Research — Brownsville, Texas (7.1 mi)
· Sponsor: Novo Nordisk A/S
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Texas Oncology - Central South (Pease) — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Peripheral T Cell Lymphoma
Phase 3
Interventional 504 participants sought
Valley Cancer Associates — Harlingen, Texas (19.9 mi)
· Sponsor: Acrotech Biopharma Inc.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Brownsville, Texas (7.1 mi)
· Sponsor: AstraZeneca
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
N/A
Observational 2,450 participants sought
Texas Digestive — Harlingen, Texas (19.9 mi)
· Sponsor: Harbinger Health
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohn Disease
Phase 2
Interventional 212 participants sought
Texas Digestive Specialists — Harlingen, Texas (19.9 mi)
· Sponsor: Abivax S.A.
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 980 participants sought
Valley Institute of Research-Site Number: 8400004 — Harlingen, Texas (19.9 mi)
· Sponsor: Sanofi
cHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury
Spinal Cord Injuries
N/A
Interventional 40 participants sought
University of Texas - Rio Grande Valley — Harlingen, Texas (19.9 mi)
· Sponsor: University of Minnesota
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Texas Oncology- Central South — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Phase 3
Interventional 318 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer